# Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia

> **NCT01896336** · PHASE4 · COMPLETED · sponsor: **EMS** · enrollment: 67 (actual)

## Conditions studied

- Primary Insomnia

## Interventions

- **DRUG:** Zolpidem Hemitartrate

## Key facts

- **NCT ID:** NCT01896336
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-18
- **Primary completion:** 2013-11-11
- **Final completion:** 2013-12-10
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2021-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01896336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01896336, "Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01896336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*